Investing

Following the collapse of the French government, the risk premium on French debt decreased from its highest point in over a decade. This shift occurred on Thursday when the premium…

Neuralink, the brain technology firm led by Elon Musk, has been cited by the Food and Drug Administration (FDA) for “objectionable conditions or practices” at its animal testing laboratory in…

By Maria Martinez BERLIN (Reuters) – For Eva Henschke, Germany’s Christmas markets are a chance to temporarily forget about the colder, darker days with a hot mug of mulled wine…

PARIS (Reuters) – The fall of the government leaves France without a clear path toward reducing its budgetary deficit, credit rating agency Standard and Poor’s (NYSE:SPY) (S&P) said on Thursday.…

By Promit Mukherjee OTTAWA (Reuters) – Canada’s fiscal targets over the next few years will be tougher to achieve as a promised Christmas handout last month by Prime Minister Justin…

By Rachael Levy (Reuters) – An animal testing laboratory at Elon Musk’s Neuralink brain technology company was found to have “objectionable conditions or practices” by the Food and Drug Administration,…

By Stefano Rebaudo (Reuters) – The risk premium investors demand to hold French debt rather than German Bunds dropped from its highest levels in over 12 years on Thursday after…

FRANKFURT (Reuters) – Following are quotes from ECB policymakers in the run-up to the Dec 12 policy meeting where a rate cut is almost certain and only the size is…

Investing.com — Goldman Sachs strategists continue to forecast consecutive 25 basis-point rate cuts in December, January, and March, followed by additional reductions in June and September. However, they note that…